glp-1 heart disease medications are not just for weight loss — they are the most important drug class of our lifetime. 🫀 A 2025 meta-analysis of 99,599 patients confirmed: ✓ 20% reduction in major GLP-1 Agonists Enhance Cardiac Metabolism

Amgen is developing monthly GLP-1 injections aimed at improving convenience and long-term adherence for patients.

Approved for adults and children age 10+ with type 2 diabetes.

Common side effects of dulaglutide include nausea, diarrhea, and abdominal distension, and these are usually mild to moderate in severity and tend to diminish over time

Exploring new therapeutic pathways with cautious optimism - By Buonsenso and the Kids

Methods Blood was drawn from 24 subjects (14 male, 10 female, age: 50.77.36years, BMI: 26.643.38kg/m2, GHbA1c: 7.000.74%) with drug-nave T2D at 0 and 120min following a standard mixed meal for the measurements of active GLP-1, NO and NOS